| T group n = 18 | TL group n = 38 | p-value |
mean (range) | |||
SVA |
|
|
|
Pre-op | 78.4 (−25 - 137) | 69.9 (−59 - 232) | 0.5819 |
1-month post-op | 21.9 (−22 - 79) | 33.4 (−32 - 90) | 0.23 |
final follow-up | 59.3 (−9 - 158) | 66.7 (−22 - 157) | 0.5887 |
C7PL-CSVL |
|
|
|
Pre-op | 14.2 (0 - 90) | 20.9 (1 - 38) | 0.21 |
1-month post-op | 15.9 (0 - 38) | 11.2 (0 - 46) | 0.1308 |
final follow-up | 9.2 (0 - 39) | 10.3 (0 - 55) | 0.7648 |
LL |
|
|
|
Pre-op | 11.7 (−14 - 56) | 21.6 (−32 - 47) | 0.0848 |
1-month post-op | 43.3 (12 - 65) | 38.7 (2 - 70) | 0.231 |
final follow-up | 38.3 (13 - 61) | 36.4 (2 - 60) | 0.5937 |
PT |
|
|
|
Pre-op | 27.8 (10 - 56) | 28.5 (13 - 47) | 0.82 |
1-month post-op | 18.0 (4 - 50) | 24.3 (5 - 46) | 0.0367* |
final follow-up | 18.5 (7 - 51) | 26.2 (7 - 48) | 0.009374* |
PI |
|
|
|
Pre-op | 45.0 (31 - 70) | 49.1 (24 - 70) | 0.16 |
1-month post-op | 45.2 (31 - 70) | 49.3 (24 - 70) | 0.164 |
final follow-up | 45.7 (32 - 70) | 49.5 (24 - 70) | 0.1933 |
PI-LL |
|
|
|
Pre-op | 33.5 (2 - 75) | 27.4 (−25 - 62) | 0.269 |
1-month post-op | 2.9 (−28 - 32) | 10.5 (−19 - 46) | 0.35 |
final follow-up | 7.3 (−17 - 32) | 13.1 (−18 - 39) | 0.134 |
SS |
|
|
|
Pre-op | 18.1 (3 - 32) | 20.7 (−7 - 36) | 0.367 |
1-month post-op | 27.4 (6 - 40) | 25.7 (9 - 49) | 0.463 |
final follow-up | 23.8 (4 - 36) | 20.7 (7 - 40) | 0.1309 |